Union Budget@10: Has Modi government delivered on Ease of Doing Business promise?
Rudra Kumar Pandey
Shardul Amarchand Mangaldas advised Eris Lifesciences Limited on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited in India
Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (“Eris”) on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited (“Biocon”) in India. The deal is valued at approximately INR 366 crores and the date of closing the deal was 10 November 2023. This acquisition marks the entry of Eris into… Read More +
Cyber insurance: An evolving story
Shailaja Lall, Akshay Sachthey and Christina Shaju
RBI to establish cloud facility for financial sector for enhanced data security
Shilpa Mankar Ahluwalia